| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Revenue | $9.06B | +16.7% |
| Cost of Revenue | $5.34B | +14.7% |
| Gross Profit | $3.72B | +19.8% |
| R&D Expense | $529.5M | +20.1% |
| SG&A Expense | $2.02B | +14.5% |
| Interest Expense | $135.3M | +9.8% |
| Pre-tax Income | $1.61B | +49.8% |
| Income Tax | $330.5M | +113.9% |
| Net Income | $1.39B |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.07B | +118.4% |
| Short-term Investments | $600K | -95.2% |
| Accounts Receivable | $2.17B | +24.8% |
| Inventory | $1.40B | +33.3% |
| Current Assets | $4.91B | +36.0% |
| Total Assets | $11.30B | +5.1% |
| Current Liabilities | $3.37B | -5.8% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.37B | +67.0% |
| Capital Expenditures | $160.5M | +13.7% |
| Investing Cash Flow | $854.3M | — |
| Financing Cash Flow | -$1.68B | -79.4% |
| Free Cash Flow | $1.21B | +78.0% |
| +48.8% |
| EPS (Basic) | $12.03 | +50.0% |
| EPS (Diluted) | $11.95 | +49.9% |
| Long-term Debt |
| $2.86B |
| -0.2% |
| Stockholders' Equity | $3.56B | +30.7% |